Latest news
Iconovo carries out a directed issue of shares of approx. SEK 25 million and a rights issue of shares of approx. SEK 24.6 million
The Board of Directors of Iconovo AB ("Iconovo" or the "Company") has today resolved on a directed share issue of approximately SEK 25 million (the…
Iconovo appoints Anders Månsson as new CEO
Iconovo AB (publ), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, has today appointed Anders…
Press releases
Nov 28, 2019, 18:30
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
Nov 28, 2019, 18:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Nov 19, 2019, 15:09
News
IR
Swedish
Corporate Information
Other Corporate Information
Nov 19, 2019, 15:09
News
IR
English
Corporate Information
Other Corporate Information
Nov 08, 2019, 10:51
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 05, 2019, 09:48
News
IR
English
Corporate Information
Other Corporate Information
Nov 05, 2019, 09:48
News
IR
Swedish
Corporate Information
Other Corporate Information
Oct 25, 2019, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Oct 25, 2019, 08:15
News
IR
English
Corporate Information
Other Corporate Information
Oct 25, 2019, 08:15
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 16, 2019, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Jul 10, 2019, 14:23
News
IR
Swedish
Corporate Information
Other Corporate Information
May 15, 2019, 19:26
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 03, 2019, 16:26
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 25, 2019, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Apr 18, 2019, 09:20
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 15, 2019, 09:21
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Mar 29, 2019, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 19, 2019, 21:17
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 19, 2019, 21:09
News
IR
Swedish
Corporate Information
Other Corporate Information
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se